Yeah, the MRI approval will level that portion of the playing field between the various companies. It's one of the points of competition. However, the Algovita system is better than Abbott or Medtronic currently; even without that approval.
Only Boston's system is better, IMO.
I have not heard anything rumor-wise about the FDA. I'm assuming I'll hear when the larger market does, but if I hear a rumor I'll pass it on.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.